Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and immunogenicity of Bexsero in healthy adolescents 12 to <19 years
2014-003822-42Phase 4Completed
- Sponsor
- Pfizer
- Start
- Nov 2014
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of meningococcal group B vaccine in meningococcal disease and meningococcal meningitis, sponsored by Pfizer. Started Nov 2014; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
meningococcal diseasemeningococcal meningitis
Beyond the preview
Go deeper on 2014-003822-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003822-42.